UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015765 |
|---|---|
| Receipt number | R000018296 |
| Scientific Title | A Phase II Study of Capecitabine, Oxaliplatin (XELOX) and Bevacizumab for patient with high-risk Upper Rectal Cancer as Neo-Adjuvant chemotherapy. |
| Date of disclosure of the study information | 2014/12/01 |
| Last modified on | 2020/06/01 20:28:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/11/27 00:07:45 | ||
| 2 | Update | 2014/12/01 12:32:49 | Institute Institute |
|
| 3 | Update | 2014/12/03 16:22:04 | UMIN ID1 |
|
| 4 | Update | 2016/06/27 11:28:28 | Name of primary person or sponsor Organization Email1 |
|
| 5 | Update | 2018/11/29 16:55:28 | Email1 |
|
| 6 | Update | 2020/06/01 09:44:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2020/06/01 09:47:15 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2020/06/01 20:28:53 | Number of participants that the trial has enrolled |
